ストックスクリーナーアプリを入手
466.42
0.03%
-0.15
プレマーケット:
466.15
-0.27
-0.06%
前日終値:
$466.57
開ける：
$466.98
24時間の取引高:
1.98M
Relative Volume:
0.71
時価総額：
$176.07B
収益：
$43.21B
当期純損益:
$6.58B
株価収益率:
26.98
EPS:
17.29
ネットキャッシュフロー:
$6.17B
1週間 パフォーマンス:
-3.26%
1か月 パフォーマンス:
+8.64%
6か月 パフォーマンス:
-19.91%
1年 パフォーマンス:
-22.01%
1日の値動き範囲:
$464.84
$469.87
1週間の範囲:
$451.45
$484.88
52週間の値動き範囲:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
466.42 | 176.18B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.04 | 141.39B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.94 | 54.91B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.89 | 32.62B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
183.93 | 31.07B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-24 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Thermo Fisher launches two microscopes - Scientist Live
Here’s Why Kovitz Core Equity Strategy Increased Its Position in Thermo Fisher Scientific (TMO) - Insider Monkey
Proteomics Market Top PlayersThermo Fisher Scientific, Inc. - openPR.com
Thermo Fisher Scientific Falls 0.03% as $920M Volume Ranks 93rd on Strong Institutional Buying and Upgraded Analyst Targets - AInvest
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations - GlobeNewswire Inc.
Thermo Fisher plots 85 layoffs in California as its cost-cutting crusade marches on - Fierce Pharma
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Insider Monkey
Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends - sg.finance.yahoo.com
Proteomics Market Growth and Future Scope 2025-2032 | Thermo - openPR.com
Thermo Fisher Scientific introduces Applied Biosystems MagMAX HMW DNA Kit - European Pharmaceutical Manufacturer
Energy giant GE Vernova's market cap is now the largest in Mass. - The Business Journals
Thermo Fisher: New Headwinds Could Delay The Industry's Recovery (NYSE:TMO) - Seeking Alpha
Contract Manufacturing Market Forecast to 2030, with Case Studies of Thermo Fisher Scientific and Flextronics - GlobeNewswire
What makes Thermo Fisher Scientific Inc. stock price move sharplyFree Stock Market Forecast Reports - Jammu Links News
Does Thermo Fisher Scientific Inc. stock perform well during market downturnsBuild a winning investment strategy - Jammu Links News
What are the latest earnings results for Thermo Fisher Scientific Inc.Invest like a pro with expert recommendations - Jammu Links News
What is the dividend policy of Thermo Fisher Scientific Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
What catalysts could drive Thermo Fisher Scientific Inc. stock higher in 2025Breakout stock performance - Jammu Links News
Is Thermo Fisher Scientific Inc. stock overvalued or undervaluedStrong return on investment - jammulinksnews.com
How does Thermo Fisher Scientific Inc. generate profit in a changing economyExplosive trading opportunities - jammulinksnews.com
Stifel Reaffirms Buy on Thermo Fisher (TMO) Despite Price Target Cut - Insider Monkey
Thermo Fisher 2025 Q2 Earnings Strong Performance as Net Income Grows 4% - AInvest
THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation - Yahoo Finance
Why Thermo Fisher Scientific Inc. stock attracts strong analyst attentionMomentum Based Equity Trading Plans Reviewed - beatles.ru
How does Thermo Fisher Scientific Inc. compare to its industry peersMarket Forecast Insights For 2025 - Jammu Links News
Here’s Why Thermo Fisher Scientific (TMO) Traded Down in Q2 - Insider Monkey
Global G-Protein Coupled Receptors Market [2025-2032] - openPR.com
Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific - Yahoo Finance
Drug Abuse Testing Market Forecast and Company Analysis - GlobeNewswire
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance
5 Insightful Analyst Questions From Thermo Fisher’s Q2 Earnings Call - TradingView
Thermo Fisher Margins Feel The Weight Of Tariffs Even As China Trade Pressures Ease In Q2 - insights.citeline.com
Thermo Fisher's Q2 revenue and EPS beat estimates, driven by Life Sciences Solutions growth and strong product launches. - AInvest
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ... - Yahoo Finance
Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450 - MSN
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now - MSN
Thermo Fisher Scientific showcases diagnostics solutions designed to meet evolving global healthcare demands at ADLM 2025 - SelectScience
North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - Yahoo Finance
Thermo Fisher Scientific EVP Pettiti Sells 400 Shares at $479.98/Share. - AInvest
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid market shifts - Investing.com
COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn - openPR.com
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth - MSN
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025 - 01net
Cell Reprogramming Market Future Business Opportunities - openPR.com
How many analysts rate Thermo Fisher Scientific Inc. as a “Buy”Outstanding risk-reward balance - jammulinksnews.com
What is the risk reward ratio of investing in Thermo Fisher Scientific Inc. stockInvest confidently with expert support - jammulinksnews.com
Is Thermo Fisher Scientific Inc. a growth stock or a value stockExponential return rates - jammulinksnews.com
Thermo Fisher Scientific's (TMO) Q2 Outperformance and Revised Price Target: Is Now the Time to Buy? - AInvest
Refurbished Laboratory Equipment Market Top Companies Study - openPR.com
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.80%
5.98%
大文字化:
|
ボリューム (24 時間):